Evogene Ltd EVGN 深 沪
已收盘 07-02 16:00:00 美东时间
0.4297
-0.011
-2.56%
华盛通- 最 高0.4499
- 今 开0.42
- 成交量 7.62万股
- 最 低 0.4195
- 昨 收 0.441
- 总市值 520.13万
- 52周最高 1.50
- 市盈率 静 --
- 换手率 0.63%
- 52周最低 0.37
- 委 比 -78.93%
- 总股本 1210.45万
- 历史最高 203.90
- 量 比 0.19
- 振 幅 6.89%
- 历史最低 0.37
- 每 手 1
- 风险率 0.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.
Evogene ( ($EVGN) ) has shared an announcement. On June 11, 2026, Evogene Ltd. ...
06-12 04:28
Full Transcript: Evogene Q1 2026 Earnings Call
Evogene (NASDAQ:EVGN) reported first-quarter financial results on Wednesday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/ap...
06-11 18:51
Evogene Reports Early Results for Cancer Therapy Study, Experimental Treatment Meets Safety Goal in First Human Trial
Evogene Ltd. ("Evogene") (NASDAQ:EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in generative design of small molecules for the pharmaceutical and agricultural industries, today announced
06-02 19:06
Evogene Files Secondary Offering Of 2,446,707 Shares By Selling Shareholder
- SEC filing
05-20 20:53
Earnings Scheduled For May 20, 2026
Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is likely to re...
05-20 19:11
Evogene misses Q1 estimates
Evogene press release (EVGN): Q1 GAAP EPS of -$0.60 misses by $0.33. Revenue of $0.3M (-100.0% Y/Y) misses by $0.05M. As of March 31, 2026, Evogene held consolidated cash, cash equivalents, and short...
05-20 19:06
Evogene Q1 EPS $(0.60) Misses $(0.27) Estimate, Sales $334.000K Miss $350.000K Estimate
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.27) by 122.22 percent. This is a 57.89 percent decrease over losses of $(0.38) per share from the
05-20 19:01
Evogene to Present at the 24th Schrödinger European User Group Meeting
Conference will be held in Munich, Germany - May 19-21, 2026 REHOVOT, Israel, May 12, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational che...
05-12 20:00
Evogene receives Nasdaq notification
Evogene Ltd. (NASDAQ: EVGN) said on Thursday it had received a notice from the Nasdaq indicating that it had fallen out of compliance with Nasdaq Rule 5550(a)(2) after its shares had closed below $1.0...
04-03 04:09
Evogene Receives Nasdaq Noncompliance Notification, Gets Time Through Sept. 28 To Regain Compliance
Evogene Ltd. (NASDAQ:EVGN)(TASE: EVGN) (the "Company", "Evogene"), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural
04-03 04:02
